Diabetes Mellitus, Experimental
|
disease |
Nutritional and Metabolic Diseases; Endocrine System Diseases
|
Experimental Model of Disease
|
522
|
|
0.200 |
None |
1.000 |
1 |
|
1997 |
1997 |
Autoimmune Diseases
|
group |
Immune System Diseases
|
Disease or Syndrome
|
1758
|
428
|
0.010 |
None |
1.000 |
1 |
|
2002 |
2002 |
Sarcoidosis
|
disease |
Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
413
|
787
|
0.010 |
None |
1.000 |
1 |
|
2002 |
2002 |
Anaplastic carcinoma
|
disease |
Neoplasms
|
Neoplastic Process
|
232
|
3
|
0.300 |
None |
1.000 |
1 |
|
2005 |
2005 |
Carcinoma, Spindle-Cell
|
disease |
Neoplasms
|
Neoplastic Process
|
218
|
5
|
0.300 |
None |
1.000 |
1 |
|
2005 |
2005 |
Undifferentiated carcinoma
|
disease |
Neoplasms
|
Neoplastic Process
|
283
|
8
|
0.300 |
None |
1.000 |
1 |
|
2005 |
2005 |
Mammary Neoplasms, Experimental
|
phenotype |
Neoplasms
|
Neoplastic Process; Experimental Model of Disease
|
218
|
|
0.300 |
None |
1.000 |
1 |
|
2005 |
2005 |
Mammary Carcinoma, Animal
|
disease |
Neoplasms; Animal Diseases
|
Neoplastic Process
|
144
|
|
0.300 |
None |
1.000 |
1 |
|
2005 |
2005 |
Animal Mammary Neoplasms
|
phenotype |
Neoplasms; Animal Diseases
|
Neoplastic Process
|
147
|
|
0.300 |
None |
1.000 |
1 |
|
2005 |
2005 |
Carcinomatosis
|
phenotype |
Neoplasms
|
Neoplastic Process
|
186
|
2
|
0.300 |
None |
1.000 |
1 |
|
2005 |
2005 |
Carcinoma
|
group |
Neoplasms
|
Neoplastic Process
|
2462
|
103
|
0.300 |
None |
1.000 |
1 |
|
2005 |
2005 |
Decreased adipose tissue
|
phenotype |
|
Sign or Symptom
|
17
|
|
0.010 |
None |
1.000 |
1 |
|
2006 |
2006 |
Hyperandrogenism
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases; Endocrine System Diseases
|
Disease or Syndrome
|
108
|
24
|
0.010 |
None |
1.000 |
1 |
|
2007 |
2007 |
Insulin Resistance
|
phenotype |
Nutritional and Metabolic Diseases
|
Pathologic Function
|
162
|
53
|
0.200 |
None |
1.000 |
1 |
|
2007 |
2007 |
Erectile dysfunction
|
disease |
Male Urogenital Diseases; Mental Disorders
|
Disease or Syndrome
|
256
|
44
|
0.200 |
None |
1.000 |
1 |
|
2007 |
2007 |
Pre-Eclampsia
|
phenotype |
Female Urogenital Diseases and Pregnancy Complications
|
Pathologic Function
|
166
|
14
|
0.010 |
None |
1.000 |
1 |
|
2008 |
2008 |
Polycystic Ovary Syndrome
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases
|
Disease or Syndrome
|
988
|
363
|
0.020 |
None |
1.000 |
2 |
3
|
2007 |
2009 |
Carcinoma, Transitional Cell
|
disease |
Neoplasms
|
Neoplastic Process
|
623
|
12
|
0.010 |
None |
1.000 |
1 |
|
2009 |
2009 |
Thromboangiitis Obliterans
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
127
|
16
|
0.010 |
None |
1.000 |
1 |
|
2010 |
2010 |
Lipodystrophy
|
disease |
Nutritional and Metabolic Diseases; Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
226
|
28
|
0.010 |
None |
1.000 |
1 |
|
2011 |
2011 |
HIV-1 infection
|
disease |
|
Disease or Syndrome
|
695
|
94
|
0.010 |
None |
1.000 |
1 |
|
2011 |
2011 |
Carotid Stenosis
|
disease |
Nervous System Diseases; Cardiovascular Diseases
|
Disease or Syndrome
|
135
|
19
|
0.010 |
None |
1.000 |
1 |
|
2011 |
2011 |
Secondary Neoplasm
|
group |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
2492
|
85
|
0.010 |
None |
1.000 |
1 |
|
2011 |
2011 |
Osteoporosis
|
disease |
Nutritional and Metabolic Diseases; Musculoskeletal Diseases
|
Disease or Syndrome
|
1098
|
182
|
0.010 |
None |
1.000 |
1 |
|
2011 |
2011 |
Medulloblastoma
|
disease |
Neoplasms
|
Neoplastic Process
|
862
|
115
|
0.010 |
None |
1.000 |
1 |
|
2012 |
2012 |